Atorvastatin Market Report 2025 (Global Edition)

Global Atorvastatin Market Report 2024 Market Size Split by Application (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Product (Chemical Synthesis, Biocatalysis)

Atorvastatin Market Report Description

We have various report editions of Atorvastatin Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Atorvastatin Market Insights Video

Competitive Landscape of the Atorvastatin Market

The company leaders in the atorvastatin industry differentiate their products and constantly innovate to stay ahead of the competition. Competition for generic alternatives has heated up, resulting in lower prices. Companies are also funding studies to find out if atorvastatin has any other medical use. Partnerships and collaborations in the pharmaceutical industry impact market dynamics by increasing the availability and accessibility of atorvastatin-based medicines on a worldwide scale.

In September 2024, Apotex Inc. signed a deal with Formosa Pharmaceuticals granting Apotex the exclusive right to market and distribute APP13007 (clobetasol propionate ophthalmic suspension, 0.05%) in Canada for the duration of its approval. (Source: https://www.apotex.com/global/about-us/news/2024/08/07/apotex-expands-ophthalmic-franchise-through-the-acquisition-of-canadian-rights-to-app13007-(clobetasol-propionate-ophthalmic-suspension--0.05-)--a-novel-steroid-for-ophthalmology In September 2024, Teva Pharmaceuticals and Sanofi, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., announced a change to the program’s schedule for studying the human IgG1-?2 monoclonal antibody targeting TL1A for moderate-to-severe inflammatory bowel disease (IBD). The program was previously known as TEV-‘574/SAR447189. (Source: https://www.tevapharm.com/news-and-media/latest-news/teva-and-sanofi-announce-accelerated-timeline-for-anti-tl1a-phase-2b-program-in-patients-with-inflammator/ In August 2024, Pfizer Inc. unveiled PfizerForAll, a user-friendly digital platform meant to enable seamless access to healthcare and management of health and wellness for people throughout the United States. (Source: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-launches-pfizerforalltm-digital-platform-helps)

Top Companies Market Share in Atorvastatin Industry: (In no particular order of Rank)

• Pfizer Inc.
• DSM
• Teva Pharmaceutical Industries
• Mylan Pharmaceuticals Inc.
• Cadila Healthcare Limited
• Apotex Inc
• Dr Reddy’s Laboratories Limited
• Sandoz Inc.
• Lupin Pharmaceuticals
• Inc.
• Lannett Company
• Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Atorvastatin Market

Which Region Dominates the Atorvastatin Market in 2024?

According to Cognitive Market Research, North America currently dominates the atorvastatin market, and the region is expected to have significant growth during the projected period. This is because cardiovascular problems are very common, and people are becoming more conscious of the need to regulate their cholesterol levels. Additional factors that contribute to the market’s growth include a favorable regulatory climate, strong R&D efforts, and a robust healthcare infrastructure. Atorvastatin is more readily available in the area because of the presence of important pharmaceutical businesses.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR) due to it putting more money into healthcare, escalating rates of cardiovascular disease, rising levels of disposable income, and better access to healthcare. Furthermore, the developing pharmaceutical infrastructure and the increasing public awareness of the need for cholesterol treatment are also driving the market growth in this area.

The current report Scope analyzes Atorvastatin Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Atorvastatin

According to Cognitive Market Research, the global atorvastatin market size was estimated at USD 4624.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 1849.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.0% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the atorvastatin market with a market size of USD 1459.40 million in 2024 and is projected to grow at a CAGR of 1.8% during the forecast period. The U.S. market's stringent governmental healthcare regulations.
• The Canada atorvastatin market had a market share of USD 221.96 million in 2024 and is projected to grow at a CAGR of 2.8% during the forecast period. Canada’s rising cardiovascular awareness among populations.
• The Mexico atorvastatin market is projected to witness growth at a CAGR of 2.5% during the forecast period, with a market size of USD 168.32 million in 2024.

Europe Atorvastatin

According to Cognitive Market Research, the global atorvastatin market size was estimated at USD 4624.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 1387.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.3% from 2024 to 2031.

• The United Kingdom atorvastatin market had a market share of USD 233.06 million in 2024 and is projected to grow at a CAGR of 3.1% during the forecast period. In the UK, atorvastatin sales witness an upswing due to the nation's rising demand for innovative atorvastatin technology.
• The France atorvastatin market is projected to witness growth at a CAGR of 1.5% during the forecast period, with a market size of USD 127.63 million in 2024.
• According to Cognitive Market Research, the German atorvastatin market size was valued at USD 274.68 million in 2024 and is projected to grow at a CAGR of 2.5% during the forecast period. In Germany, atorvastatin surged due to the presence of major market players.
• The Italy atorvastatin market is projected to witness growth at a CAGR of 1.7% during the forecast period, with a market size of USD 119.30 million in 2024.
• The Russia atorvastatin market is projected to witness growth at a CAGR of 1.3% during the forecast period, with a market size of USD 215.03 million in 2024.
• The Spain atorvastatin market is projected to witness growth at a CAGR of 1.4% during the forecast period with a market size of USD 113.76 million in 2024
• The Luxembourg atorvastatin market is projected to witness growth at a CAGR of 2.4% during the forecast period, with a market size of USD 43.01 million in 2024.
• The Portugal atorvastatin market is projected to witness growth at a CAGR of 2.1% during the forecast period, with a market size of USD 29.13 million in 2024.
• The Greece atorvastatin market is projected to witness growth at a CAGR of 2.6% during the forecast period, with a market size of USD 16.65 million in 2024.
• The Rest of Europe's atorvastatin market is projected to witness growth at a CAGR of 1.0% during the forecast period, with a market size of USD 215.03 million in 2024.

Asia Pacific Atorvastatin

According to Cognitive Market Research, the global atorvastatin market size was estimated at USD 4624.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 1063.57 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.

• According to Cognitive Market Research, the China atorvastatin market size was valued at USD 478.60 million in 2024 and is projected to grow at a CAGR of 5.3% during the forecast period. Atorvastatin surged in China due to the rising elderly population.
• The Japan atorvastatin market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 146.77 million in 2024.
• The India atorvastatin market had a market share of USD 127.63 million in 2024 and is projected to grow at a CAGR of 7.6% during the forecast period. India's robust healthcare infrastructure.
• The South Korean atorvastatin market is projected to witness growth at a CAGR of 4.9% during the forecast period, with a market size of USD 106.36 million in 2024.
• The Australian atorvastatin market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 55.31 million in 2024.
• The Southeast Asia atorvastatin market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 73.39 million in 2024.
• The Rest of Asia Pacific atorvastatin market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 75.51 million in 2024.

South America Atorvastatin

According to Cognitive Market Research, the global atorvastatin market size was estimated at USD 4624.2 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 231.21 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil atorvastatin market size was valued at USD 98.96 million in 2024 and is projected to grow at a CAGR of 3.8% during the forecast period. Atorvastatin flourished in Brazil due to increasing disposable income.
• Argentina's atorvastatin market had a market share of USD 38.84 million in 2024 and is projected to grow at a CAGR of 4.1% during the forecast period. Argentina's rising government initiatives.
• Colombia’s atorvastatin market is projected to witness growth at a CAGR of 3.0% during the forecast period, with a market size of USD 20.58 million in 2024.
• Peru’s atorvastatin market is projected to witness growth at a CAGR of 3.4% during the forecast period, with a market size of USD 18.96 million in 2024.
• Chile’s atorvastatin market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD 16.65 million in 2024.
• The Rest of Latin America's atorvastatin market is projected to witness growth at a CAGR of 2.3% during the forecast period, with a market size of USD 37.22 million in 2024.

Middle East and Africa Atorvastatin

According to Cognitive Market Research, the global atorvastatin market size was estimated at USD 4624.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 92.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.5% from 2024 to 2031..

• The GCC Countries’ atorvastatin market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 39.58 million in 2024. Atorvastatin sales flourish due to the presence of major market players.
• The Egypt atorvastatin market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 9.71 million in 2024.
• The South Africa atorvastatin market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 14.61 million in 2024. Atorvastatin sales flourished in South Africa due to increasing regulatory support.
• The Turkey atorvastatin market is projected to witness growth at a CAGR of 3.0% during the forecast period, with a market size of USD 7.95 million in 2024.
• The Nigeria atorvastatin market is projected to witness growth at a CAGR of 2.6% during the forecast period, with a market size of USD 9.71 million in 2024.
• The Rest of the MEA atorvastatin market is projected to witness growth at a CAGR of 2.5% during the forecast period, with a market size of USD 10.91 million in 2024.

Atorvastatin Market Analysis

Atorvastatin Market Application Segment Analysis

According to Cognitive Market Research, hospital pharmacy is likely to dominate the atorvastatin market over the forecast period. Because of the vital function they play in the care of individuals suffering from cardiovascular disorders. Atorvastatin is in great demand because of the rising number of hospitalizations and the increasing number of people with high cholesterol. Moreover, hospital pharmacies also have a strong position in the market because they provide patients with easy access to their drugs, which helps with patient management and treatment regimen adherence.

The online pharmacy is the fastest-growing segment in the atorvastatin market. Because discreet and easy access to drugs is becoming more and more desirable to consumers. Due to the convenience of online shopping and the increasing need for cholesterol medication, atorvastatin is now more affordable and accessible than ever before.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Atorvastatin Industry. Request a Free Sample PDF!

Atorvastatin Market Product Segment Analysis

According to Cognitive Market Research, the chemical synthesis segment holds the largest share of the market. This is because it uses well-established processes to produce atorvastatin economically and efficiently. Chemical synthesis is the method of choice for mass production and satisfying consumer demand because it permits exact control over product quality and consistency.

In the atorvastatin market, biocatalysis has been growing quickly. Because of the eco-friendly and efficient manufacturing methods it employs. Biocatalysis, which makes use of microorganisms, is in line with sustainability trends since it lessens the need for harmful chemicals and creates less waste. Biocatalysis also improves the quality of the product by allowing for improved yields and selectivity in the synthesis of atorvastatin. Additionally, biocatalysis is becoming more popular among pharmaceutical companies looking for sustainable and novel ways to make drugs in response to rising regulatory demands for greener manufacturing processes.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion